Profile data is unavailable for this security.
About the company
Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The Company has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
- Revenue in USD (TTM)0.00
- Net income in USD1.52m
- Incorporated2023
- Employees--
- LocationPsyence Biomedical Ltd121 Richmond Street West PenthouseSuite 1300TORONTO M5H 2K1CanadaCAN
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 4.52m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
| Halberd Corp | 281.24k | 25.34k | 4.74m | 3.00 | 3.21 | -- | 186.73 | 16.84 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
| Enveric Biosciences Inc | 0.00 | -15.11m | 4.81m | 7.00 | -- | 0.6979 | -- | -- | -6.46 | -6.46 | 0.00 | 0.8887 | 0.00 | -- | -- | 0.00 | -122.02 | -104.94 | -178.49 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
| Adial Pharmaceuticals Inc | 0.00 | -11.24m | 4.83m | 4.00 | -- | 0.7551 | -- | -- | -6.01 | -3.75 | 0.00 | 1.51 | 0.00 | -- | -- | 0.00 | -212.33 | -182.35 | -273.26 | -235.45 | -- | -- | -- | -- | -- | -20.20 | 0.00 | -- | -- | -- | 35.14 | -- | -- | -- |
| Creative Medical Technology Holdings Inc | 9.00k | -5.28m | 4.83m | 4.00 | -- | 0.5255 | -- | 536.25 | -3.74 | -3.74 | 0.0064 | 6.81 | 0.0007 | 0.4291 | -- | 2,250.00 | -42.47 | -110.00 | -43.88 | -- | 60.00 | 65.82 | -58,624.33 | -7,961.14 | 23.53 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
| Biofrontera Inc | 33.25m | -23.09m | 4.83m | 85.00 | -- | -- | -- | 0.1454 | -12.47 | -12.47 | 16.84 | -0.3627 | 0.9995 | 2.50 | 5.75 | 391,200.00 | -69.40 | -- | -144.06 | -- | 48.99 | -- | -69.44 | -- | 0.944 | -3.55 | 4.63 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| AccuStem Sciences Inc | 0.00 | -1.74m | 4.84m | 3.00 | -- | -- | -- | -- | -0.1537 | -0.1537 | 0.00 | -0.2309 | 0.00 | -- | -- | 0.00 | -1,168.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| Emmaus Life Sciences Inc | 28.46m | -4.74m | 4.88m | 55.00 | -- | -- | -- | 0.1715 | -0.0931 | -0.0931 | 0.3905 | -0.6773 | 0.6349 | 0.8184 | 9.36 | 517,454.50 | -10.58 | -- | -- | -- | 93.69 | -- | -16.66 | -- | 0.1249 | 0.1426 | -- | -- | -10.77 | -- | 33.37 | -- | -- | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 4.93m | -- | -- | -- | 3.25 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| HST Global Inc | 0.00 | -141.11k | 4.99m | 1.00 | -- | -- | -- | -- | -0.0269 | -0.0269 | 0.00 | -0.1193 | 0.00 | -- | -- | -- | -29,397.92 | -5,836.01 | -- | -- | -- | -- | -- | -- | -- | -24.24 | -- | -- | -- | -- | -0.7858 | -- | -- | -- |
| Pineapple Inc | 157.59k | 376.69k | 5.12m | -- | 0.6283 | -- | 13.43 | 32.47 | 0.1114 | 0.1114 | 0.0028 | -0.0318 | 0.0388 | -- | -- | -- | 9.28 | -- | 53.43 | -- | -412.55 | -- | 239.03 | -- | 0.00 | -- | -- | -- | -- | -- | -611.10 | -- | -- | -- |
| Ainos Inc | 93.68k | -14.56m | 5.15m | 46.00 | -- | 0.2222 | -- | 55.01 | -3.27 | -3.27 | 0.0206 | 3.69 | 0.0028 | 0.8133 | 1.62 | 2,036.52 | -43.83 | -36.36 | -48.64 | -58.33 | -222.11 | 36.82 | -15,547.49 | -813.63 | 0.2847 | -75.23 | 0.2003 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
| Helix BioMedix, Inc. | 2.07m | -2.58m | 5.23m | 8.00 | -- | 3.35 | -- | 2.53 | -15.60 | -15.60 | 12.48 | 6.95 | 0.8047 | 1.87 | 4.55 | 258,238.80 | -100.64 | -146.31 | -120.73 | -173.57 | 68.96 | 30.80 | -125.06 | -527.12 | 1.69 | -14.57 | 0.00 | -- | 122.07 | 92.80 | 67.73 | -- | -29.08 | -- |
| Tonix Pharmaceuticals Holding Corp | 10.25m | -98.59m | 5.23m | 103.00 | -- | 0.0266 | -- | 0.5104 | -177.41 | -177.41 | 9.46 | 46.94 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
Data as of Jun 26 2024. Currency figures normalised to Psyence Biomedical Ltd's reporting currency: US Dollar USD
15.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harraden Circle Investments LLCas of 25 Jan 2024 | 1.30m | 9.71% |
| Cantor Fitzgerald & Co.as of 31 Mar 2024 | 337.00k | 2.52% |
| AdvisorShares Investments LLCas of 31 Mar 2024 | 271.34k | 2.03% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 55.78k | 0.42% |
| Virtu Americas LLCas of 31 Mar 2024 | 26.42k | 0.20% |
| TD Securities (USA) LLCas of 31 Mar 2024 | 25.00k | 0.19% |
| HRT Financial LLCas of 31 Mar 2024 | 12.61k | 0.09% |
| Geode Capital Management LLCas of 31 Mar 2024 | 10.49k | 0.08% |
| UBS Securities LLCas of 31 Mar 2024 | 2.36k | 0.02% |
| Headlands Technologies LLCas of 31 Mar 2024 | 96.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 11 Jun 2024Source: FactSet Research Systems Inc.
